3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Thrombosis
1
Squamous Cell Carcinoma of Head and Neck
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Salivary Gland Neoplasms
1
Radiation Injuries
1
Protein Metabolism
1
Pain
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Mucositis
1
Malnutrition
1
Hemorrhage
1
Glioblastoma
1
Erectile Dysfunction
1
Disease
1
Diabetes Insipidus
1
Interventions
Tranexamic Acid
6
Sodium Chloride
2
Ringer's Lactate
2
maleimide-polyethylene glycol-modified hemoglobin, MP4
1
bemiparin
1
Uterine Artery Embolization
1
Tourniquets
1
Sutures
1
Surgicel
1
Saline Solution
1
Rivaroxaban
1
Ringer's Solution
1
Pancreaticoduodenectomy
1
Mannitol
1
Lenalidomide
1
Ibuprofen
1
Goserelin
1
Gonadotropin-Releasing Hormone
1
Furosemide
1
FloSeal Matrix
1
Esomeprazole
1
Data Collection
1
Dalteparin
1
Crystalloid Solutions
1
Colloids
1
Blood Transfusion
1
Bevacizumab
1
Aspirin
1
Arginine Vasopressin
1
Arginine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hemorrhage
×
Arginine
×
Clear all
NCT05293041
2025-03-06
ARG-01
Sahlgrenska University Hospital
Phase 4
Completed
248 enrolled